- Global Pharma News & Resources

Lundbeck increases its share capital by 11,497 shares (0.0058 % of outstanding shares) as a result of exercise of employee warrants

Valby, Denmark, 19 February 2020 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 57,485 as a consequence of the exercise of employee warrants.

The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following prices per share of nominally DKK 5: 11,497 shares at DKK 113. Proceeds to the company are DKK 1,299,161 (approximately USD 0.192 million). The increase corresponds to approximately 0.0058 % of the company's share capital.

The new shares are ordinary shares without any special rights and are freely transferable negotiable instruments. The new shares shall give rights to dividends and other rights in relation to the company from the time of registration of the capital increase. The new shares will be listed on NASDAQ OMX Copenhagen after registration with the Danish Business Authority.

Lundbeck's current share capital amounts to DKK 995,683,625. The capital increase is expected to be finalized shortly, and the total number of voting rights and the total share capital will after this capital increase be:


Number of shares (nominal value DKK 5)

Nominal value of shares (DKK)

           Number of votes               





Editor Details

  • Company:
    • Lundbeck
  • Name:
    • Lundbeck
Last Updated: 19-Feb-2020